SECURKLOUD

Healthcare Triangle Inc.’s subsidiary QuantumNexis Inc. launched operations in Dubai’s Meydan Free Zone to deliver clinically validated digital mental health solutions and an AI-powered hospital information system across GCC markets. QuantumNexis said it will integrate Ezovion Health OS and Ziloy.ai, supported by a strategic partnership with Better.care and alignment with Microsoft and Better.care partner ecosystems.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Healthcare Triangle Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202602270718PR_NEWS_USPR_____SF97663) on February 27, 2026, and is solely responsible for the information contained therein.

Healthcare Triangle Inc.’s subsidiary QuantumNexis, including QuantumNexis Malaysia Sdn Bhd, has entered a strategic partnership with TNG Digital to integrate its Ziloy digital mental health platform into the TNG eWallet. The collaboration aims to deliver clinically validated mental health support to more than 25 million users in Malaysia, featuring in-app discovery, single sign-on, and payments through TNG eWallet.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Healthcare Triangle Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202602251610PR_NEWS_USPR_____SF95588) on February 25, 2026, and is solely responsible for the information contained therein.

Healthcare Triangle, Inc. will implement a 1-for-60 reverse stock split of its common stock, effective February 10, 2026. The move is part of the company's plan to regain compliance with the Nasdaq Capital Market's minimum bid price requirement. The stock will continue trading under the symbol "HCTI" with a new CUSIP number.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Healthcare Triangle Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-016390), on February 13, 2026, and is solely responsible for the information contained therein.

Healthcare Triangle Inc. hat am 2. Februar 2026 eine außerordentliche Hauptversammlung abgehalten. Die Aktionäre haben einer Änderung der Satzung zur Durchführung eines Reverse Splits der Stammaktien im Verhältnis von 1:2 bis 1:100 zugestimmt. Außerdem wurde der Vorschlag angenommen, die Versammlung gegebenenfalls zu vertagen, um zusätzliche Stimmrechtsvollmachten einzuholen.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Healthcare Triangle Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-013262), on February 06, 2026, and is solely responsible for the information contained therein.

Healthcare Triangle Inc., through its subsidiary QuantumNexis, has announced a joint venture with Golden Code Holdings to accelerate the digital health transformation in Saudi Arabia. The collaboration aims to address the rapidly growing Saudi healthcare market, projected to reach $70 billion by 2030, and to support the Kingdom's Vision 2030 and digital health strategy. The joint venture will establish a regional hub for digital health innovation, introduce advanced AI-powered platforms, and drive workforce development initiatives, with a focus on building a data-driven, interoperable, and value-based healthcare ecosystem in Saudi Arabia.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Healthcare Triangle Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: SF80699) on February 05, 2026, and is solely responsible for the information contained therein.

Healthcare Triangle Inc. has entered into a Development Program Agreement with Better, a global digital healthcare platform provider. This partnership aims to expand Healthcare Triangle's health data platform services across Europe, Southeast Asia, the Middle East, and Africa. As part of the collaboration, Healthcare Triangle and its subsidiary QuantumNexis will gain access to structured training and certification programs to accelerate the adoption of Better’s solutions. The agreement positions Healthcare Triangle as a preferred service provider in high-growth healthcare markets, targeting countries such as India, Malaysia, Indonesia, the Philippines, Saudi Arabia, and multiple African nations. The partnership is intended to advance digital health innovation and support the adoption of modern, interoperable healthcare systems focused on improving patient outcomes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Healthcare Triangle Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: SF74039) on January 29, 2026, and is solely responsible for the information contained therein.

Healthcare Triangle, Inc. has entered into a definitive agreement with Teyame AI LLC as part of its planned acquisition of Teyame 360 SL and Datono Mediacion SL, both Spain-based companies specializing in AI-powered omnichannel customer experience solutions. The transaction is expected to generate $38 million in incremental next twelve months (NTM) revenue and $5 million in incremental NTM EBITDA, while expanding Healthcare Triangle's SaaS footprint in Europe and Latin America. The deal is valued at up to approximately $50 million, comprising cash, common stock, non-voting convertible preferred stock, and contingent earnout-based equity consideration. The transaction is anticipated to be effective from January 1, 2026, with closing expected on January 29, 2026, subject to customary conditions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Healthcare Triangle Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-008594), on January 28, 2026, and is solely responsible for the information contained therein.

Healthcare Triangle, Inc. has signed a definitive agreement with Teyame AI LLC to acquire the shares of Teyame 360 SL and Datono Mediacion SL, Spain-based companies specializing in AI-powered omnichannel customer experience solutions. The transaction, valued at up to approximately $50 million in a mix of cash, stock, and contingent equity, is expected to be effective as of January 1, 2026. The deal is forecasted to generate $38 million in incremental next twelve months (NTM) revenue and $5 million in incremental NTM EBITDA, expanding Healthcare Triangle’s SaaS footprint in Europe and Latin America. Financial information provided by Teyame indicates the acquired assets generated around $32 million in revenue and $3.6 million in EBITDA for fiscal year 2025. Healthcare Triangle states that integrating these platforms will advance its strategy in AI-driven healthcare innovation and global patient engagement.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Healthcare Triangle Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: SF68608) on January 22, 2026, and is solely responsible for the information contained therein.

Healthcare Triangle, Inc. has signed a Letter of Intent to acquire Spain-based Teyame.AI, a move expected to generate approximately $34 million in incremental annual revenue and $4.2 million in additional EBITDA. The acquisition will combine Teyame.AI's advanced AI automation platform-currently serving banking and insurance clients and piloting healthcare applications-with Healthcare Triangle's expertise in clinical systems. This integration aims to create a comprehensive, AI-powered patient engagement platform and expand the company's reach into international markets. The announcement was made by Healthcare Triangle, Inc.

Healthcare Triangle Inc. has signed a non-binding Letter of Intent to acquire the assets of Teyame.AI LLC, a Spain-based company specializing in AI-powered omnichannel customer experience solutions. The proposed acquisition would bring Teyame's advanced AI automation platform under Healthcare Triangle's umbrella, with the aim of creating a next-generation global customer engagement ecosystem for healthcare. Teyame is projected to generate approximately $34 million in revenue and $4.2 million in EBITDA for fiscal year 2025. The integration is expected to enable intelligent automation for treatment plans, chronic care workflows, and patient outreach, while also expanding Healthcare Triangle's reach into international markets and enhancing its innovation team with Teyame's AI and automation experts.

Healthcare Triangle Inc. has announced that it has entered into warrant exercise agreements with certain accredited and institutional investors, resulting in the immediate exercise of outstanding warrants to purchase 812,775 shares of common stock. This transaction will generate approximately $1.63 million in gross proceeds for the company. In connection with the exercise, the company has agreed to reduce the exercise price of the existing warrants from $20.92 to $2.00 per share. Participating investors will also receive new unregistered warrants to purchase up to 812,775 shares of common stock at an exercise price of $3.00 per share, exercisable upon stockholder approval and expiring five years from that date. WallachBeth Capital is acting as the sole placement agent for this warrant inducement transaction.

Healthcare Triangle Inc. (Nasdaq: HCTI) has announced a private placement transaction involving the exercise of outstanding warrants by certain accredited and institutional investors. The company has entered into agreements for the immediate exercise of warrants to purchase a total of 377,702 shares of common stock, generating approximately $755,000 in gross cash proceeds. In return, participating investors will receive new unregistered warrants to purchase up to 377,702 additional shares at an exercise price of $3.00 per share. The new warrants are immediately exercisable and will expire five years from the date of issuance. As part of the transaction, the exercise price of the existing warrants was reduced from $20.92 to $2.00 per share. WallachBeth Capital is serving as financial advisor for the transaction.

Healthcare Triangle Inc. (Nasdaq: HCTI) has entered into warrant exercise agreements with three accredited investors, resulting in the immediate exercise of outstanding warrants to purchase a total of 812,775 shares of common stock. This transaction will provide the company with approximately $1.63 million in gross cash proceeds. In exchange, the exercising investors will receive new unregistered warrants to purchase up to 812,775 additional shares at an exercise price of $3.00 per share. The exercise price of the existing warrants was reduced from $20.92 to $2.00 per share as part of the agreement. WallachBeth Capital is acting as the sole placement agent for this transaction. The new warrants will become exercisable following stockholder approval and will expire five years from that date.

Healthcare Triangle Inc.'s wholly-owned subsidiary, QuantumNexis, has processed over $20 million in end-user revenue through its Ezovion Electronic Medical Record (EMR) platform. The company forecasts this figure will reach $37 million within six months, driven by rapid international expansion and deeper engagement with existing customers. QuantumNexis is also preparing to launch an integrated payment gateway in late 2025, aiming to turn platform activity into recurring revenue and support global scaling throughout 2026.

Healthcare Triangle Inc. has announced that its 2025 Annual Meeting of Stockholders will be held virtually on October 31, 2025. During the meeting, stockholders will be asked to vote on the election of four nominees for director and the ratification of the appointment of the company's independent registered public accounting firm.

Healthcare Triangle, Inc. (Nasdaq: HCTI) announced a 1-for-249 reverse stock split, effective August 1, 2025, as part of its strategy to comply with Nasdaq's $1.00 minimum bid price requirement. The company's common stock will continue trading under the symbol "HCTI," with a new CUSIP number 42227W 306. The reverse split is intended to increase the stock's price per share.

Healthcare Triangle Inc. has announced a regulatory issue concerning its continued listing on the Nasdaq Stock Market. The company received notices from Nasdaq indicating non-compliance with several listing rules. Initially, the company failed to meet the Minimum Bid Price Requirement, with its securities trading below $1 for 30 consecutive days. Further, Nasdaq raised public interest concerns due to substantial shareholder dilution from a private placement. Additionally, the company's securities recorded a closing bid price of $0.10 or less for ten consecutive trading days, triggering the Low Priced Stocks Rule. Healthcare Triangle Inc. has responded to the Nasdaq Hearings Panel and is exploring alternative actions to regain compliance. However, there is no assurance of meeting the necessary listing requirements.